Press release
Liquid Biopsy Market is Growing at CAGR of 18% to Achieve US$ 24.70 Billion by 2033
Liquid Biopsy Market
Liquid biopsy technology has emerged as a disruptive force in cancer diagnostics, offering non-invasive and highly sensitive approaches for cancer detection and surveillance. This innovative technique has garnered substantial interest and witnessed tremendous growth due to its potential to revolutionize cancer treatment. Liquid biopsies detect cancer biomarkers, such as those from breast biopsy, in physiological fluids like blood and urine.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐จ๐ฉ๐ฒ ๐จ๐ ๐๐ก๐ข๐ฌ ๐๐๐ฉ๐จ๐ซ๐ญ:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9040
In the realm of cancer diagnosis and treatment, a groundbreaking technology known as liquid biopsy is rapidly gaining traction, revolutionizing the way cancers are detected and monitored. Liquid biopsy involves the analysis of biomarkers, such as circulating tumor cells (CTCs), cell-free DNA (cfDNA), and exosomes, which are shed by tumors into bodily fluids like blood or urine. This non-invasive approach offers numerous advantages over traditional tissue biopsies, including early detection, real-time monitoring of treatment response, and the potential for personalized therapy selection. As this innovative technology gains momentum, the liquid biopsy market is experiencing significant growth and transformation.
One of the key drivers propelling the liquid biopsy market forward is the increasing prevalence of cancer worldwide. With cancer incidence rates on the rise and early detection being critical for improving patient outcomes, there is a growing demand for non-invasive and highly sensitive diagnostic tools. Liquid biopsy meets this need by providing a minimally invasive method for detecting cancer-related biomarkers with high specificity and sensitivity.
Moreover, liquid biopsy offers several advantages over conventional tissue biopsies, which often require invasive procedures and may not always yield representative samples. Liquid biopsy can be performed more frequently and with minimal discomfort to the patient, allowing for real-time monitoring of disease progression and treatment response. Additionally, liquid biopsy enables the detection of tumor heterogeneity, allowing clinicians to better understand the genetic makeup of a patient's cancer and tailor treatment strategies accordingly.
The versatility of liquid biopsy extends beyond cancer detection to encompass a wide range of applications, including monitoring minimal residual disease, assessing treatment response, and detecting drug resistance mutations. This multifaceted approach has led to the adoption of liquid biopsy across various cancer types, including lung, breast, colorectal, and prostate cancer, among others.
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ:
Bio-Rad Laboratories
Biocept Inc.
Guardant Health
Illumina Inc.
F. Hoffman-La Roche Ltd.
Johnson & Johnson
Laboratory Corporation of America Holdings
MDxHealth SA
QIAGEN N.V
Thermo Fisher Scientific Inc.
QIAGEN;
Myriad Genetics, Inc;
ANGLE plc
Oncimmune
Lucence Health, Inc.
Freenome Holdings, Inc.
Epigenomics AG
Natera, Inc.
๐๐๐๐ ๐๐จ๐ซ๐:https://www.factmr.com/report/liquid-biopsy-market
๐๐จ๐ฆ๐ฉ๐๐ญ๐ข๐ญ๐ข๐ฏ๐ ๐๐๐ง๐๐ฌ๐๐๐ฉ๐:
The global liquid biopsy market features a diverse array of companies, from established diagnostic leaders to innovative startups, vying for prominence in this dynamic industry.
Illumina, Inc., renowned for its genetic sequencing technology, leads the charge by providing essential high-throughput sequencing technologies crucial for various liquid biopsy procedures.
Guardant Health has swiftly gained recognition and market share with its groundbreaking ctDNA analysis technique, revolutionizing cancer detection.
Biocept specializes in offering comprehensive liquid biopsy testing services, ensuring reliable cancer detection and monitoring for patients.
Personal Genome Diagnostics (PGDx), with a focus on precision oncology, provides liquid biopsy solutions to assist in cancer diagnosis and treatment selection, contributing to personalized patient care.
Natera, known for its ctDNA testing platform, has made significant strides in both prenatal and cancer liquid biopsy industries, pushing the boundaries of innovation.
This competitive landscape, comprising a mix of established market leaders and innovative newcomers, fosters the ongoing evolution and expansion of the market, promising exciting advancements in cancer diagnostics.
๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง ๐จ๐ ๐๐ข๐ช๐ฎ๐ข๐ ๐๐ข๐จ๐ฉ๐ฌ๐ฒ ๐๐๐ซ๐ค๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก
By Product & Service :
Assay Kits
Instruments
Software and Services
By Circulating Biomarker :
Circulating Tumor Cells (CTCs)
Cell-free DNA
Circulating Cell-free RNA
Exosomes & Extracellular Vesicles
Others
By Indication :
Cancer
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Melanoma
Others
Non-cancer
Non-invasive Prenatal Testing (NIPT)
Organ Transplantations
Infectious Disease Testing
Others
By Technology :
Multi-gene-parallel Analysis (NGS)
Single-gene Analysis (PCR Microarrays)
By Clinical Application :
Routine Screening
Patient Work-up
Therapy Selection
Treatment Monitoring
Recurrence Monitoring
Others
By Sample Type :
Blood
Urine
Saliva
Others
By End User :
Hospitals & Laboratories
Specialty Centers
Research Institutes
Others
By Region :
North America
Europe
Latin America
East Asia
South Asia & Oceania
Middle East & Africa
The liquid biopsy market is experiencing rapid growth as revolutionary cancer detection technology gains momentum. With its non-invasive nature, high sensitivity, and versatility, liquid biopsy is poised to transform cancer diagnosis and treatment, offering new hope for patients and healthcare providers alike. As research and development efforts continue to advance, liquid biopsy holds the potential to revolutionize the way cancer is managed, ultimately improving patient outcomes and saving lives.
๐๐จ๐ฉ ๐๐๐ฅ๐๐ญ๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ข๐ง ๐ญ๐ก๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ
Blood Collection Tubes for Liquid Biopsy Market
https://www.factmr.com/report/4495/blood-collection-tubes-for-liquid-biopsy-market
Breast Biopsy Marker Market
https://www.factmr.com/report/breast-biopsy-marker-market
Bone Biopsy Systems Market
https://www.factmr.com/report/3884/bone-biopsy-systems-market
๐๐จ๐ง๐ญ๐๐๐ญ:
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com
๐๐๐จ๐ฎ๐ญ ๐ ๐๐๐ญ.๐๐
We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Liquid Biopsy Market is Growing at CAGR of 18% to Achieve US$ 24.70 Billion by 2033 here
News-ID: 3385186 • Views: โฆ
More Releases from Fact.MR
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decodingโฆ
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke โฆ
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleanersโฆ
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offeringโฆ
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 โฆ
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhanceโฆ
More Releases for Liquid
Vitamins: The Liquid Goldmine in the Booming Liquid Dietary Supplements Market
The liquid dietary supplements market is experiencing a surge in popularity, driven by consumers seeking convenient and effective ways to boost their health and wellness. Among the diverse offerings, the vitamins segment stands out as a high-opportunity area, catering to a wide range of health needs and preferences.
Market Dynamics and Growth Drivers
Liquid vitamins offer a compelling alternative to traditional pills and capsules, providing faster absorption, easier consumption, and customizable dosages.โฆ
Thermoelectric Assemblies Market, By Type (Air to Air, Direct to Air, Liquid to โฆ
The thermoelectric assemblies market is expected to witness market growth at a rate of 8.25% in the forecast period of 2021 to 2028. Data Bridge Market Research report on thermoelectric assemblies market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in the application of thermoelectric assemblies in the food and beverage industryโฆ
Southeast Asia Liquid Gases Market : Growing with a CAGR of 7.1%, By Type (Liqui โฆ
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged productsโฆ
Southeast Asia Liquid Gases Market growing with a CAGR of 7.1%, By Type (Liquid โฆ
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged productsโฆ
Southeast Asia liquid gases market growing with a CAGR of 7.1%, Size, Share, Tre โฆ
Southeast Asia liquid gases market is expected to grow significantly in the forecast period of 2023 to 2030. Data Bridge Market Research analyses that the market is growing with a CAGR of 7.1% in the forecast period of 2023 to 2030 and is expected to reach USD 5,042,237.33 thousand by 2030. The major factor driving the growth of the liquid gases market is the rising demand of fresh packaged productsโฆ
Dual Chamber Prefilled Syringes Market 2021 by Product (Liquid/Powder, Liquid/Li โฆ
The Dual Chamber Prefilled Syringes Market report examines the market size by vital countries/regions, product type, application, historical data, and estimate to forecast. It helps to understand the structure of the Dual Chamber Prefilled Syringes Market by recognizing its different sub-segments. Furthermore, the report focuses on key market players to determine, describe and analyze the value, market share, market competition landscape, SWOT analysis, and development plans in the next fewโฆ
